PTEN and prostate cancer: Comparison of GSK3ß expression with several of the most frequent genomic deletions in prostate cancer (PTEN, 3p13, 6q15 and 5q21) revealed that GSK3ß staining was strikingly linked to PTEN deletions (p < 0,0001, Figure 5).